Skip to main content

Advertisement

Log in

The liver: another organ involved in Muir Torre syndrome?

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Muir Torre syndrome is a rare autosomal dominant cancer-predisposing syndrome characterized by the occurrence of sebaceous gland neoplasms and/or keratoacanthomas associated with visceral malignancies that belong to the spectrum of hereditary non polyposis colorectal cancer (HNPCC), i.e., tumors of gastrointestinal and genitourinary tracts. Hepatobiliary malignancy in association with Muir Torre syndrome has rarely been reported. Here, we describe a case of Muir Torre syndrome associated with an hepatocellular-carcinoma in a patient with a non-cirrhotic liver and an HNPCC-family with multiple cases of hepatocellular carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

MTS:

Muir-Torre syndrome

HNPCC:

Hereditary non polyposis colorectal cancer

HCC:

Hepatocellular carcinoma

FNAB:

Fine needle aspiration biopsy

HOMA:

Homeostasis model assessment

NAFLD:

Non alcoholic fatty liver disease

References

  1. Muir EG, Bell AJ, Barlow KA (1967) Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face. Br J Surg 54:191–195

    Article  PubMed  CAS  Google Scholar 

  2. Torre D (1968) Multiple sebaceous tumours. Arch Dermatol 98:549–551

    Article  PubMed  CAS  Google Scholar 

  3. Schwartz RA, Torre DP (1995) The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 33:90–104

    Article  PubMed  CAS  Google Scholar 

  4. Ponti G, de Ponz Leon M, Maffei S et al (2005) Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 68:442–447

    Article  PubMed  CAS  Google Scholar 

  5. Honchel R, Halling KC, Schaid DJ et al (1994) Microsatellite instability in Muir-Torre syndrome. Cancer Res 54:1159–1163

    PubMed  CAS  Google Scholar 

  6. Lynch HT, de la Chapelle A (2003) Genomic medicina: hereditary colorectal cancer. N Engl J Med 348:919–932

    Article  PubMed  CAS  Google Scholar 

  7. Lazar AJ, Lyle S, Calonje E (2007) Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol 13:301–319

    Article  PubMed  Google Scholar 

  8. Vernez M, Hutter P, Monnerat C et al (2007) A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene. Fam Cancer 6:141–145

    Article  PubMed  CAS  Google Scholar 

  9. Akhtar S, Oza KK, Khan SA et al (1999) Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 41:681–686

    Article  PubMed  CAS  Google Scholar 

  10. Chhibber V, Dresser K, Mahalingam M (2008) MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome. Mod Pathol 21:159–164

    PubMed  CAS  Google Scholar 

  11. Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:1453–1456

    Article  PubMed  CAS  Google Scholar 

  12. Bellentani S, Saccoccio G, Costa G et al (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. The dionysos study group. Gut 41:845–850

    Article  PubMed  CAS  Google Scholar 

  13. Barrow E, Robinson L, Alduaij W et al (2009) Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75:141–149

    Article  PubMed  CAS  Google Scholar 

  14. Zhang YZ, Sheng J-Q, Li S-R et al (2005) Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population. World J Gastroenterol 11:1481–1488

    PubMed  Google Scholar 

  15. Takagi K, Esumi M, Takano S et al (1998) Replication error frequencies in primary hepatocellular carcinoma: a comparison of solitary primary versus multiple primary cancers. Liver 18:272–276

    PubMed  CAS  Google Scholar 

  16. Salvucci M, Lemoine A, Saffroy R et al (1999) Microsatellite instability in European hepatocellular carcinoma. Oncogene 18:181–187

    Article  PubMed  CAS  Google Scholar 

  17. Chiappini F, Gross-Goupil M, Saffroy R et al (2004) Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. Carcinogenesis 25:541–547

    Article  PubMed  CAS  Google Scholar 

  18. Han HJ, Yanagisawa A, Kato Y et al (1993) Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53:5087–5089

    PubMed  CAS  Google Scholar 

  19. Saeki A, Tamura S, Ito N et al (2000) Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients. Cancer 88:1025–1029

    Article  PubMed  CAS  Google Scholar 

  20. Wang L, Bani-Hani A, Montoya DP et al (2001) hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 19:567–570

    PubMed  CAS  Google Scholar 

  21. Togni R, Bagla N, Muiesan P et al (2009) Microsatellite instability in hepatocellular carcinoma in non-cirrhotic liver in patients older than 60 years. Hepatol Res 39:226–273

    Article  Google Scholar 

  22. Dores GM, Curtis RE, Toro JR et al (2008) Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer 113:3372–3381

    Article  PubMed  Google Scholar 

  23. Fattovich G, Stroffolini T, Zagni I et al (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50

    Article  PubMed  Google Scholar 

  24. Cohen PR, Kohn SR, Kurzrock R (1991) Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 90:606–613

    PubMed  CAS  Google Scholar 

  25. Stella A, Surdo NC, Lastella P et al (2007) Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clin Genet 71:130–139

    Article  PubMed  CAS  Google Scholar 

  26. Colon cancer gene variant databases© 2004–2011 Leiden University Medical Center. (http://chromium.liacs.nl/LOVD2/colon_cancer/home.php)

  27. Thiffault I, Hamel N, Pal T et al (2004) Germline truncating mutations in both MSH2 and BRCA2 in a single kindred. Br J Cancer 90:483–491

    Article  PubMed  CAS  Google Scholar 

  28. Stucklessr S, Parfrey PS, Woods MO et al (2007) The phenotypic expression of 3 MSH2 mutations in large newfoundland families with Lynch syndrome. Fam Cancer 6:1–12

    Article  Google Scholar 

  29. Levi Z, Hazai R, Kedar-Barnes I et al (2007) Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Am J Transpl 7:476–479

    Article  CAS  Google Scholar 

  30. Sethi A, Straviz RT (2007) Review article: medical management of the liver transplant recipient: a primer for non-transplant doctors. Aliment Pharmacol Ther 25:229–245

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Angeli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morando, F., Alaibac, M., Romano, A. et al. The liver: another organ involved in Muir Torre syndrome?. Familial Cancer 11, 7–12 (2012). https://doi.org/10.1007/s10689-011-9450-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-011-9450-1

Keywords

Navigation